Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility

Cell

Volumn 166, Issue 2, 2016, Pages 328-342

  Denny, Sarah K ^a   Yang, Dian ^a   Chuang, Chen Hua ^a   Brady, Jennifer J ^a   Lim, Jing Shan ^a   Grüner, Barbara M ^a   Chiou, Shin Heng ^a   Schep, Alicia N ^a   Baral, Jessika ^a   Hamard, Cécile ^c   Antoine, Martine ^c   Wislez, Marie ^c   Kong, Christina S ^a   Connolly, Andrew J ^a   Park, Kwon Sik ^d   Sage, Julien ^a,b   Greenleaf, William J ^a,e   Winslow, Monte M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c HÔPITAL TENON   (France)

^d UNIVERSITY OF VIRGINIA   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR I; TRANSCRIPTION FACTOR NFIB; UNCLASSIFIED DRUG; NFIB PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CHROMATIN; CHROMATIN ACCESSIBILITY; CONTROLLED STUDY; DISTANT METASTASIS; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; GENE REPLICATION; GENETICALLY ENGINEERED MOUSE STRAIN; GENOME-WIDE ASSOCIATION STUDY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; METASTASIS; MOUSE; NONHUMAN; NUCLEOSOME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROTEIN MOTIF; SMALL CELL LUNG CANCER; TRANSCRIPTION INITIATION SITE; UPREGULATION; ANIMAL; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID MOTIFS; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; SMALL CELL LUNG CARCINOMA; UP-REGULATION;

EID: 84978379634     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.05.052     Document Type: Article

References (51)

1. Alevizopoulos, A., Dusserre, Y., Tsai-Pflugfelder, M., von der Weid, T., Wahli, W., Mermod, N., A proline-rich TGF-beta-responsive transcriptional activator interacts with histone H3. Genes Dev. 9 (1995), 3051–3066.
2. Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P.D., Lee, V., Tan, C., Sullivan, J.P., Larsen, J.E., et al. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc. Natl. Acad. Sci. USA 111 (2014), 14788–14793.
3. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehár, J., Kryukov, G.V., Sonkin, D., et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483 (2012), 603–607.
4. Bell, O., Tiwari, V.K., Thomä, N.H., Schübeler, D., Determinants and dynamics of genome accessibility. Nat. Rev. Genet. 12 (2011), 554–564.
5. Benos, P.V., Bulyk, M.L., Stormo, G.D., Additivity in protein-DNA interactions: how good an approximation is it?. Nucleic Acids Res. 30 (2002), 4442–4451.
6. Betancourt, J., Katzman, S., Chen, B., Nuclear factor one B regulates neural stem cell differentiation and axonal projection of corticofugal neurons. J. Comp. Neurol. 522 (2014), 6–35.
7. Blomquist, P., Li, Q., Wrange, O., The affinity of nuclear factor 1 for its DNA site is drastically reduced by nucleosome organization irrespective of its rotational or translational position. J. Biol. Chem. 271 (1996), 153–159.
8. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., Greenleaf, W.J., Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10 (2013), 1213–1218.
9. Burger, M., Glodek, A., Hartmann, T., Schmitt-Gräff, A., Silberstein, L.E., Fujii, N., Kipps, T.J., Burger, J.A., Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22 (2003), 8093–8101.
10. Chang, C.-Y., Pasolli, H.A., Giannopoulou, E.G., Guasch, G., Gronostajski, R.M., Elemento, O., Fuchs, E., NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature 495 (2013), 98–102.
11. Chen, J., Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. Adv. Cancer Res. 114 (2012), 1–20.
12. Deal, R.B., Henikoff, J.G., Henikoff, S., Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones. Science 328 (2010), 1161–1164.
13. Dooley, A.L., Winslow, M.M., Chiang, D.Y., Banerji, S., Stransky, N., Dayton, T.L., Snyder, E.L., Senna, S., Whittaker, C.A., Bronson, R.T., et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25 (2011), 1470–1475.
14. Foley, K., Rucki, A.A., Xiao, Q., Zhou, D., Leubner, A., Mo, G., Kleponis, J., Wu, A.A., Sharma, R., Jiang, Q., et al. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Sci. Signal., 8, 2015, ra77.
15. George, J., Lim, J.S., Jang, S.J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524 (2015), 47–53.
16. Grabowska, M.M., Elliott, A.D., DeGraff, D.J., Anderson, P.D., Anumanthan, G., Yamashita, H., Sun, Q., Friedman, D.B., Hachey, D.L., Yu, X., et al. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression. Mol. Endocrinol. 28 (2014), 949–964.
17. Gronostajski, R.M., Roles of the NFI/CTF gene family in transcription and development. Gene 249 (2000), 31–45.
18. Harris, L., Genovesi, L.A., Gronostajski, R.M., Wainwright, B.J., Piper, M., Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations. Dev. Dyn. 244 (2015), 227–238.
19. Hebbar, P.B., Archer, T.K., Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter. Mol. Cell. Biol. 23 (2003), 887–898.
20. Hou, J.M., Krebs, M.G., Lancashire, L., Sloane, R., Backen, A., Swain, R.K., Priest, L.J., Greystoke, A., Zhou, C., Morris, K., et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J. Clin. Oncol. 30 (2012), 525–532.
21. Kalemkerian, G.P., Akerley, W., Bogner, P., Borghaei, H., Chow, L.Q., Downey, R.J., Gandhi, L., Ganti, A.K., Govindan, R., Grecula, J.C., et al., National Comprehensive Cancer Network. Small cell lung cancer. J. Natl. Compr. Canc. Netw. 11 (2013), 78–98.
22. Ko, S.Y., Blatch, G.L., Dass, C.R., Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer. Cancer Metastasis Rev. 33 (2014), 101–113.
23. Lin, C.Y., Loven, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I., Young, R.A., Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151 (2012), 56–67.
24. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
25. Meisterernst, M., Gander, I., Rogge, L., Winnacker, E.L., A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res. 16 (1988), 4419–4435.
26. Meuwissen, R., Linn, S.C., Linnoila, R.I., Zevenhoven, J., Mooi, W.J., Berns, A., Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4 (2003), 181–189.
27. Mohammad, H.P., Smitheman, K.N., Kamat, C.D., Soong, D., Federowicz, K.E., Van Aller, G.S., Schneck, J.L., Carson, J.D., Liu, Y., Butticello, M., et al. A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC. Cancer Cell 28 (2015), 57–69.
28. Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., Luo, L., A global double-fluorescent Cre reporter mouse. Genesis 45 (2007), 593–605.
29. Nakazawa, K., Kurishima, K., Tamura, T., Kagohashi, K., Ishikawa, H., Satoh, H., Hizawa, N., Specific organ metastases and survival in small cell lung cancer. Oncol. Lett. 4 (2012), 617–620.
30. Osborne, J.K., Larsen, J.E., Shields, M.D., Gonzales, J.X., Shames, D.S., Sato, M., Kulkarni, A., Wistuba, I.I., Girard, L., Minna, J.D., Cobb, M.H., NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. Proc. Natl. Acad. Sci. USA 110 (2013), 6524–6529.
31. Peifer, M., Fernández-Cuesta, L., Sos, M.L., George, J., Seidel, D., Kasper, L.H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44 (2012), 1104–1110.
32. Rudin, C.M., Durinck, S., Stawiski, E.W., Poirier, J.T., Modrusan, Z., Shames, D.S., Bergbower, E.A., Guan, Y., Shin, J., Guillory, J., et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44 (2012), 1111–1116.
33. Schaffer, B.E., Park, K.S., Yiu, G., Conklin, J.F., Lin, C., Burkhart, D.L., Karnezis, A.N., Sweet-Cordero, E.A., Sage, J., Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 70 (2010), 3877–3883.
34. Schep, A.N., Buenrostro, J.D., Denny, S.K., Schwartz, K., Sherlock, G., Greenleaf, W.J., Structured nucleosome fingerprints enable high-resolution mapping of chromatin architecture within regulatory regions. Genome Res. 25 (2015), 1757–1770.
35. Schones, D.E., Zhao, K., Genome-wide approaches to studying chromatin modifications. Nat. Rev. Genet. 9 (2008), 179–191.
36. Sethi, N., Kang, Y., Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat. Rev. Cancer 11 (2011), 735–748.
37. Simon, J.M., Hacker, K.E., Singh, D., Brannon, A.R., Parker, J.S., Weiser, M., Ho, T.H., Kuan, P.F., Jonasch, E., Furey, T.S., et al. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Res. 24 (2014), 241–250.
38. Steele-Perkins, G., Plachez, C., Butz, K.G., Yang, G., Bachurski, C.J., Kinsman, S.L., Litwack, E.D., Richards, L.J., Gronostajski, R.M., The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol. Cell. Biol. 25 (2005), 685–698.
39. Stergachis, A.B., Neph, S., Reynolds, A., Humbert, R., Miller, B., Paige, S.L., Vernot, B., Cheng, J.B., Thurman, R.E., Sandstrom, R., et al. Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 154 (2013), 888–903.
40. Sung, M.-H., Guertin, M.J., Baek, S., Hager, G.L., DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol. Cell 56 (2014), 275–285.
41. Sung, M.-H., Baek, S., Hager, G.L., Genome-wide footprinting: ready for prime time?. Nat. Methods 13 (2016), 222–228.
42. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B., et al. The accessible chromatin landscape of the human genome. Nature 489 (2012), 75–82.
43. van Meerbeeck, J.P., Fennell, D.A., De Ruysscher, D.K.M., Small-cell lung cancer. Lancet 378 (2011), 1741–1755.
44. Vanharanta, S., Shu, W., Brenet, F., Hakimi, A.A., Heguy, A., Viale, A., Reuter, V.E., Hsieh, J.J., Scandura, J.M., Massagué, J., Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat. Med. 19 (2013), 50–56.
45. Vierstra, J., Rynes, E., Sandstrom, R., Zhang, M., Canfield, T., Hansen, R.S., Stehling-Sun, S., Sabo, P.J., Byron, R., Humbert, R., et al. Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution. Science 346 (2014), 1007–1012.
46. Voss, T.C., Hager, G.L., Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat. Rev. Genet. 15 (2014), 69–81.
47. Yang, J., Weinberg, R.A., Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 (2008), 818–829.
48. Zaret, K.S., Mango, S.E., Pioneer transcription factors, chromatin dynamics, and cell fate control. Curr. Opin. Genet. Dev. 37 (2016), 76–81.
49. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., Liu, X.S., Model-based analysis of ChIP-seq (MACS). Genome Biol., 9, 2008, R137.
50. Zhou, W.-J., Geng, Z.H., Chi, S., Zhang, W., Niu, X.F., Lan, S.J., Ma, L., Yang, X., Wang, L.J., Ding, Y.Q., Geng, J.G., Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 21 (2011), 609–626.
51. Zhu, J., Adli, M., Zou, J.Y., Verstappen, G., Coyne, M., Zhang, X., Durham, T., Miri, M., Deshpande, V., De Jager, P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152 (2013), 642–654.